Abstract: This work presents a 2-mW 70.7-dB SNDR 200-MS/s pipelined-successive-approximation-register (SAR) analog-to-digital converter (ADC) with a continuous-time SAR-assisted detect-and-skip (CTDAS ...
Abstract: We discuss a 12-b 18-GS/s analog-to-digital converter (ADC) implemented in 16-nm FinFET process. The ADC is composed of an integrated high-speed track-and-hold amplifier (THA) driving up to ...
Former Anambra State Governor, Peter Obi’s 2027 presidential ambition is being shrouded in uncertainty as confusion continues to trail what platform he will contest the election. DAILY POST reports ...
CHENGDU, China, Oct. 11, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP2)-directed ...
Jiangsu Hengrui Pharmaceuticals’ dealmaking spree rolls on, with a potential $1.1 billion transaction on a rival to AstraZeneca and Daiichi Sankyo’s blockbuster Enhertu being the latest addition.
Imagine turning your old, “dumb” appliances into intelligent, Wi-Fi-enabled devices that respond to your voice, phone, or automation rules. Sounds futuristic, right? With the ESP8266 microcontroller, ...
Citrix NetScaler ADC and NetScaler Gateway customers have been hit by a new round of zero day vulnerabilities that require urgent patching, including one the company warned is being actively exploited ...
Ipsen has backed out of a $875 million deal for Sutro Biopharma’s ROR1-directed antibody-drug conjugate. The deal, which was signed in April 2024, saw Ipsen agree to hand over $75 million in a ...
The HER2-targeted antibody-drug conjugate that Pfizer gained from its Seagen buyout has delivered positive results in a pivotal study among Chinese patients with newly diagnosed bladder cancer, a ...
Paclitaxel, ifosfamide, cisplatin (TIP) in patients with advanced urethral adenocarcinoma: A single center, retrospective analysis. Adjuvant nivolumab (NIVO) vs placebo (PBO) for high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results